RxAll is aiming to transform the value chain of medications in Africa and beyond

Founders Factory Africa (‘FFA’) announced today that it has selected a new Health venture RxAll into its Venture Scale programme. The venture development company, along with its corporate investors Netcare Group and Standard Bank Group, are excited to welcome the business founded by CEO and Founder Adebayo Alonge, and Co-Founders Amy Kao and Wei Lui, to its 6-month bespoke program.

RxAll enables hospitals, pharmacies and patients in Africa to buy high quality, non-counterfeit medicines online by authenticating and delivering drugs through their curated marketplace. RxAll is dedicated to providing high quality medication to patients that need them. Its RxScanner is a proprietary molecular sensor device that can identify the quality of prescription drugs in 20 seconds displaying results on an IoS and Android app in real-time.

Richard Friedland, CEO of Netcare Group, says: “RxAll is an exciting venture that allows patients to have better access to high quality medication and pharmacies to access authenticated medication.”

FFA’s Venture Scale programme drives startup growth across Africa providing $300,000 investment in cash and tailored support services. In addition to the hands-on support provided, participating startups also have access to exclusive partnerships with FFA’s corporate investors, Netcare and Standard Bank, as well as other partners in FFA’s network. FFA startups are supercharged by FFA’s hands-on team, corporate partners, local knowledge, global community and investment opportunities — a unique combination that FFA term the ‘unfair advantage’.

Roo Rogers , CEO of Founders Factory Africa, says: “Counterfeit medication is a global health crisis. Its effects can be seen across the global healthcare ecosystem with over 1 million people dying globally per year. RxAll offers a unique, simple, and precise solution with its RxScanner device. FFA is excited to support RxAll's growth and impact by delivering investment, network, and growth with Adebayo Alonge and his team.”

RxAll will join FFA’s growing portfolio of African FinTech and HealthTech businesses including LocumBase (South Africa), Akili Labs (South Africa), EDAI (South Africa), WellaHealth (Nigeria), and RedBird (Ghana). Applications to the Venture Scale program are open-ended. Join here. FFA are currently specifically sourcing HealthTech startups to join the program in 2020/start of 2021.

The FFA model includes its Venture Scale programme focused on developing existing startups, whilst the Venture Build programme harnesses the power of technology to build completely new businesses solving mass needs on the African continent.